139 related articles for article (PubMed ID: 34015318)
1. Methyl palmitate protects heart against ischemia/reperfusion-induced injury through G-protein coupled receptor 40-mediated activation of the PI3K/AKT pathway.
Shen YJ; Shen YC; Lee WS; Yang KT
Eur J Pharmacol; 2021 Aug; 905():174183. PubMed ID: 34015318
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
Chang JH; Jin MM; Liu JT
Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury.
Wang J; Ji SY; Liu SZ; Jing R; Lou WJ
Pharmazie; 2015 Sep; 70(9):593-7. PubMed ID: 26492644
[TBL] [Abstract][Full Text] [Related]
4. The cardioprotective effect of dihydromyricetin prevents ischemia-reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways.
Liu S; Ai Q; Feng K; Li Y; Liu X
Apoptosis; 2016 Dec; 21(12):1366-1385. PubMed ID: 27738772
[TBL] [Abstract][Full Text] [Related]
5. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury.
Cheng XY; Gu XY; Gao Q; Zong QF; Li XH; Zhang Y
Mol Med Rep; 2016 Jul; 14(1):797-803. PubMed ID: 27221008
[TBL] [Abstract][Full Text] [Related]
6. Syringic acid mitigates myocardial ischemia reperfusion injury by activating the PI3K/Akt/GSK-3β signaling pathway.
Liu G; Zhang BF; Hu Q; Liu XP; Chen J
Biochem Biophys Res Commun; 2020 Oct; 531(2):242-249. PubMed ID: 32798018
[TBL] [Abstract][Full Text] [Related]
7. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats.
Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG
Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894
[TBL] [Abstract][Full Text] [Related]
8. α-Lipoic acid reduces infarct size and preserves cardiac function in rat myocardial ischemia/reperfusion injury through activation of PI3K/Akt/Nrf2 pathway.
Deng C; Sun Z; Tong G; Yi W; Ma L; Zhao B; Cheng L; Zhang J; Cao F; Yi D
PLoS One; 2013; 8(3):e58371. PubMed ID: 23505496
[TBL] [Abstract][Full Text] [Related]
9. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
[TBL] [Abstract][Full Text] [Related]
10. Hesperetin post-treatment prevents rat cardiomyocytes from hypoxia/reoxygenation injury in vitro via activating PI3K/Akt signaling pathway.
He S; Wang X; Zhong Y; Tang L; Zhang Y; Ling Y; Tan Z; Yang P; Chen A
Biomed Pharmacother; 2017 Jul; 91():1106-1112. PubMed ID: 28531921
[TBL] [Abstract][Full Text] [Related]
11. Evidence that the MEK/ERK but not the PI3K/Akt pathway is required for protection from myocardial ischemia-reperfusion injury by 3',4'-dihydroxyflavonol.
Thomas CJ; Lim NR; Kedikaetswe A; Yeap YY; Woodman OL; Ng DC; May CN
Eur J Pharmacol; 2015 Jul; 758():53-9. PubMed ID: 25820159
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effect of Danshensu against myocardial ischemia/reperfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation.
Yin Y; Guan Y; Duan J; Wei G; Zhu Y; Quan W; Guo C; Zhou D; Wang Y; Xi M; Wen A
Eur J Pharmacol; 2013 Jan; 699(1-3):219-26. PubMed ID: 23200898
[TBL] [Abstract][Full Text] [Related]
13. TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
Ha T; Hu Y; Liu L; Lu C; McMullen JR; Kelley J; Kao RL; Williams DL; Gao X; Li C
Cardiovasc Res; 2010 Sep; 87(4):694-703. PubMed ID: 20421349
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin gallate exerts protective effects against myocardial ischemia/reperfusion injury through the PI3K/Akt pathway-mediated inhibition of apoptosis and the restoration of the autophagic flux.
Xuan F; Jian J
Int J Mol Med; 2016 Jul; 38(1):328-36. PubMed ID: 27246989
[TBL] [Abstract][Full Text] [Related]
15. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
[TBL] [Abstract][Full Text] [Related]
16. Higenamine protects ischemia/reperfusion induced cardiac injury and myocyte apoptosis through activation of β2-AR/PI3K/AKT signaling pathway.
Wu MP; Zhang YS; Zhou QM; Xiong J; Dong YR; Yan C
Pharmacol Res; 2016 Feb; 104():115-23. PubMed ID: 26746354
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA protects against myocardial ischemia reperfusion injury by activating the PI3K/Akt/mTOR signaling pathway.
Li Q; Shen L; Wang Z; Jiang HP; Liu LX
Biomed Pharmacother; 2016 Dec; 84():106-114. PubMed ID: 27643552
[TBL] [Abstract][Full Text] [Related]
18. Tournefolic acid B, derived from Clinopodium chinense (Benth.) Kuntze, protects against myocardial ischemia/reperfusion injury by inhibiting endoplasmic reticulum stress-regulated apoptosis via PI3K/AKT pathways.
Yu Y; Xing N; Xu X; Zhu Y; Wang S; Sun G; Sun X
Phytomedicine; 2019 Jan; 52():178-186. PubMed ID: 30599897
[TBL] [Abstract][Full Text] [Related]
19. Involvement of GPR30 in protection effect of Dexmedetomidine against myocardial ischemia/reperfusion injury in rat via AKT pathway.
Shao Z; Shen Q; Kong M; Ni H; Hou X
Acta Biochim Pol; 2021 Feb; 68(1):119-126. PubMed ID: 33629579
[TBL] [Abstract][Full Text] [Related]
20. Sodium tanshinone IIA sulfonate protects rat myocardium against ischemia-reperfusion injury via activation of PI3K/Akt/FOXO3A/Bim pathway.
Zhang MQ; Zheng YL; Chen H; Tu JF; Shen Y; Guo JP; Yang XH; Yuan SR; Chen LZ; Chai JJ; Lu JH; Zhai CL
Acta Pharmacol Sin; 2013 Nov; 34(11):1386-96. PubMed ID: 24077633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
